Genotoxic changes to rodent cells exposed in Vitro to Tungsten, Nickel, Cobalt and Iron

International Journal of Environmental Research and Public Health

Volumn 11, Issue 3, 2014, Pages 2922-2940

  Bardack, Stephanie ^a   Dalgard, Clifton L ^b   Kalinich, John F ^c   Kasper, Christine E ^d,e  

^a Department of Health and Human Services   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Cancer; Fragments; Genotoxic; Military; Shrapnel; Tungsten

Indexed keywords

COBALT; EARLY GROWTH RESPONSE FACTOR 1; FRUCTOSAMINE; IRON; NICKEL; PROTEIN FOS; PROTEIN N MYRISTOYLTRANSFERASE; TUNGSTEN;

ALLOY; CANCER; COBALT; GENOTOXICITY; IRON; NICKEL; POLLUTION EXPOSURE; RODENT; TUNGSTEN;

ANIMAL CELL; AP2A1 GENE; ARTICLE; CELL CULTURE; CELL LINE; CHRND GENE; CONTROLLED STUDY; CYTOTOXICITY; EGR1 GENE; FBXW5 GENE; FN3K GENE; FOS GENE; GALNT2 GENE; GENE; GENE EXPRESSION; GENOTOXICITY; IN VITRO STUDY; MICROARRAY ANALYSIS; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; POLR3E GENE; RAT; TRANSCRIPTOMICS; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; MOUSE; MUTAGEN TESTING; NEOPLASM; PENETRATING TRAUMA; TOXICITY; WAR;

ANIMALS; CELL LINE; MICE; MUTAGENICITY TESTS; MYOBLASTS; NEOPLASMS; RATS; TUNGSTEN; WAR; WOUNDS, PENETRATING;

EID: 84897898719     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110302922     Document Type: Article

References (46)

1. Daxon, E.G.; Musk, J.H. Assessment of the Risks from Imbedded Fragments of Depleted Uranium. In AFRRI Technical Report TR93-1; Armed Forces Radiobiology Research Inst.: Bethesda, MD, USA, 1993; p. 28.
2. Hahn, F.F.; Guilmette, R.A.; Hoover, M.D. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ. Health Perspect. 2002, 110, 51-59.
3. Hodge, S.J.; Ejnik, J.; Squibb, K.S.; McDiarmid, M.A.; Morris, E.R.; Landauer, M.R.; McClain, D.E. Detection of depleted uranium in biological samples from Gulf War veterans. Mil. Med. 2001, 166, 69-70.
4. Miller, A.C.; Blakely, W.F.; Livengood, D.; Whittaker, T.; Xu, J.; Ejnik, J.W.; Hamilton, M.M.; Parlette, E.; John, T.S.; Gerstenberg, H.M.; Hsu, H. Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ. Health Perspect. 1998, 106, 465-471.
5. Miller, A.C.; Fuciarelli, A.F.; Jackson, W.E.; Ejnik, E.J.; Emond, C.; Strocko, S.; Hogan, J.; Page, N.; Pellmar, T. Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 1998, 13, 643-648.
6. McClain, D.E.; Benson, K.A.; Dalton, T.K.; Ejnik, J.; Emond, C.A.; Hodge, S.J.; Kalinich, J.F.; Landauer, M.A.; Miller, A.C.; Pellmar, T.C. et al. Biological effects of embedded depleted uranium (DU): Summary of Armed Forces Radiobiology Research Institute research. Sci. Total Environ. 2001, 274, 115-118.
7. McClain, D.E.; Benson, K.A.; Dalton, T.K.; Ejnik, J.; Emond, C.A.; Hodge, S.J.; Kalinich, J.F.; Landauer, M.R.; Livengood, D.R.; Miller, A.C. et al. Health effects of embedded depleted uranium. Mil. Med. 2002, 167, 117-119.
8. McClain, D.E.; Miller, A.C.; Kalinich, J.F. Status of Health Concerns about Military Use of Depleted Uranium and Surrogate Metals in Armor-Penetrating Munitions. In Proceedings of the Human Factors and Medicine Panel Research Task Group 099 "Radiation Bioeffects and Countermeasures" Meeting, Bethesda, MD, USA, 21-23 June 2005; Armed Forces Radiobiology Research Institute: Bethesda, MD, USA, 2005.
9. McDiarmid, M.A.; Keogh, J.P.; Hooper, F.J.; McPhaul, K.; Squibb, K.; Kane, R.; DiPino, R.; Kabat, M.; Kaup, B.; Anderson, L. et al. Health effects of depleted uranium on exposed Gulf War veterans. Environ. Res. 2000, 82, 168-180.
10. McDiarmid, M.A. Depleted uranium and public health. Br. Med. J. 2001, 322, 123-124.
11. McDiarmid, M.A.; Squibb, K.; Engelhardt, S.; Oliver, M.; Gucer, P.; Wilson, P.D.; Kane, R.; Kabat, M.; Kaup, B.; Anderson, L. et al. Surveillance of depleted uranium exposed Gulf War veterans: Health effects observed in an enlarged "friendly fire" cohort. J. Occup. Environ. Med. 2001, 43, 991-1000.
12. McDiarmid, M.A.; Hooper, F.J.; Squibb, K.; McPhaul, K.; Engelhardt, S.M.; Kane, R.; DiPino, R.; Kabat, M. Health effects and biological monitoring results of Gulf War veterans exposed to depleted uranium. Mil. Med. 2002, 167, 123-124.
13. McDiarmid, M.A.; Engelhardt, S.; Oliver, M.; Gucer, P.; Wilson, P.D.; Kane, R.; Kabat, M.; Kaup, B.; Anderson, L.; Hoover, D. et al. Health effects of depleted uranium on exposed Gulf War veterans: A 10-year follow-up. J. Toxicol. Environ. Health A 2004, 67, 277-296.
14. Miller, A.C.; Xu, J.; Stewart, M.; Prasanna, P.G.S.; Page, N. Potential late health effects of depleted uranium and tungsten used in armor-piercing munitions: Comparison of neoplastic transformation and genotoxicity with the known carcinogen nickel. Mil. Med. 2002, 167, 120-122.
15. Miller, A.C.; Brooks, K.; Stewart, M.; Anderson, B.; Shi, L.; McClain, D.; Page, N. Genomic instability in human osteoblast cells after exposure to depleted uranium: Delayed lethality and micronuclei formation. J. Environ. Radioact. 2003, 64, 247-259.
16. Miller, A.C.; Brooks, K.; Smith, J.; Page, N.; Miller, A.C.; Brooks, K.; Smith, J.; Page, N. Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2). Mol. Cell. Biochem. 2004, 255, 247-256.
17. Miller, A.C.; Beltran, D.; Rivas, R.; Stewart, M.; Merlot, R.J.; Lison, P.B. Radiation- and Depleted Uranium-Induced Carcinogenesis Studies: Characterization of the Carcinogenic Process and Development of Medical Countermeasures. In Proceedings of the Human Factors and Medicine Panel Research Task Group 099 "Radiation Bioeffects and Countermeasures" Meeting, Bethesda, MD, USA, 21-23 June 2005; Armed Forces Radiobiology Research Institute: Bethesda, MD, USA, 2005.
18. Miller, A.C.; Bonait-Pellie, C.; Merlot, R.F.; Michel, J.; Stewart, M.; Lison, P.D. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium. Mol. Cell. Biochem. 2005, 279, 97-104.
19. Pellmar, T.C.; Fuciarelli, A.F.; Ejnik, J.W.; Hamilton, M.; Hogan, J.; Strocko, S.; Emond, C.; Mottaz, H.M.; Landauer, M.R. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol. Sci. 1999, 49, 29-39.
20. Squibb, K.S.; McDiarmid, M.A. Depleted uranium exposure and health effects in Gulf War veterans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361, 639-648.
21. Davitt, R.P. A Comparison of the Advantages and Disadvantages of Depleted Uranium and Tungsten Alloy as Penetrator Materials. In Tank Ammo Section Report No. 107; US Army Armament Research and Development Command: Dover, NJ, USA, 1980; p. 32.
22. Miller, A.C.; Mog, S.; McKinney, L.; Luo, L.; Allen, J.; Xu, J.; Page, N. Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: Induction of genotoxic effects. Carcinogenesis 2001, 22, 115-125.
23. van der Voet, G.B.; Todorov, T.I.; Centeno, J.A.; Jonas, W.; Ives, J.; Mullick, F.G. Metals and health: A clinical toxicological perspective on tungsten and review of the literature. Mil. Med. 2007, 172, 1002-1005.
24. Kalinich, J.F.; Emond, C.A.; Dalton, T.K.; Mog, S.R.; Coleman, G.D.; Kordell, J.E.; Miller, A.C.; McClain, D.E. Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic high-grade rhabdomyosarcomas in F344 rats. Environ. Health Perspect. 2005, 113, 729-734.
25. Gold, K.; Cheng, Y.S.; Holmes, T.D. A quantitative analysis of aerosols inside an armored vehicle perforated by a kinetic energy penetrator containing tungsten, nickel, and cobalt. Mil. Med. 2007, 172, 393-398.
26. DoD(HA). DoD(HA) Policy on Analysis of Metal Fragments Removed from Department of Defense Personnel; Policy Letter 07-029; Office of the Assistant Secretary for Health Affairs: Washington, DC, USA, 2007.
27. Kane, M.A.; Kasper, C.E.; Kalinich, J.F. The use of established skeletal muscle cell lines to assess potential toxicity from embedded metal fragments. Toxicol. In Vitro 2009, 23, 356-359.
28. Reich, M.; Liefeld, T.; Gould, J.; Lerner, J.; Tamayo, P.; Mesirov, J.P. GenePattern 2.0. Nat. Genet. 2006, 38, 500-501.
29. Schuster, B.E.; Roszell, L.E.; Murr, L.E.; Ramirez, D.A.; Demaree, J.D.; Klotz, B.R.; Rosencrance, A.B.; Dennis, W.E.; Bao, W.; Perkins, E.J. et al. In vivo corrosion, tumor outcome, and microarray gene expression for two types of muscle-implanted tungsten alloys. Toxicol. Appl. Pharmacol. 2012, 265, 128-138.
30. Hockley, A.D.; Goldin, J.H.; Wake, M.J.; Iqbal, J. Skull repair in children. Pediatr. Neurosurg. 1990, 16, 271-275.
31. Johansson, C.B.; Hansson, H.A.; Albrektsson, T. Qualitative interfacial study between bone and tantalum, niobium or commercially pure titanium. Biomaterials 1990, 11, 277-280.
32. Fan, J.B.; Gunderson, K.L.; Bibikova, M.; Yeakley, J.M.; Chen, J.; Wickham Garcia, E.; Lebruska, L.L.; Laurent, M.; Shen, R.; Barker, D. Illumina universal bead arrays. Methods Enzymol. 2006, 410, 57-73.
33. Emond, C.E.; Vergara, V.B.; Lombardini, E.D.; Kalinich, J.F. Induction of Rhabdomyosarcoma by embedded Tungsten/Nickel/Cobalt but not by Tungsten/Nickel/Iron in the B6C3F1 mouse. 2014, In preparation.
34. Rotem-Yehudar, R.; Galperin, E.; Horowitz, M. Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J. Biol. Chem. 2001, 276, 33054-33060.
35. Conner, J.R.; Beisswenger, P.J.; Szwergold, B.S. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein. Ann. N. Y. Acad. Sci. 2005, 1043, 824-836.
36. Grassi, F.; Bouche, M.; Aguanno, S.; Molinaro, M.; Eusebi, F. Single acetylcholine-activated channels in cultured rhabdomyoblasts. Exp. Cell Res. 1987, 171, 498-502.
37. Barr, F.G.; Biegel, J.A.; Sellinger, B.; Womer, R.B.; Emanuel, B.S. Molecular and cytogenetic analysis of chromosomal arms 2q and 13q in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 1991, 3, 153-161.
38. Luther, M.A.; Schoepfer, R.; Whiting, P.; Casey, B.; Blatt, Y.; Montal, M.S.; Montal, M.; Linstrom, J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 1989, 9, 1082-1096.
39. Boone, D.N.; Qi, Y.; Li, Z.; Hann, S.R. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc. Natl. Acad. Sci. USA 2011, 108, 632-637.
40. Schiavone, D.; Avalle, L.; Dewilde, S.; Poli, V. The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3. FEBS Lett. 2011, 585, 2455-2460.
41. Delplanque, J.; Delpierre, G.; Opperdoes, F.R.; Van Schaftingen, E. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein. J. Biol. Chem. 2004, 279, 46606-46613.
42. Rioux, V.; Beauchamp, E.; Pedrono, F.; Daval, S.; Molle, D.; Catheline, D.; Legrand, P. Identification and characterization of recombinant and native rat myristoyl-CoA: Protein N-myristoyltransferases. Mol. Cell. Biochem. 2006, 286, 161-170.
43. Shrivastav, A.; Suri, S.S.; Mohr, R.; Janardhan, K.S.; Sharma, R.K.; Singh, B. Expression and activity of N-myristoyltransferase in lung inflammation of cattle and its role in neutrophil apoptosis. Vet. Res. 2010, 41, 9.
44. Kolluri, S.K.; Balduf, C.; Hofmann, M.; Gottlicher, M. Novel target genes of the Ah (dioxin) receptor: Transcriptional induction of N-myristoyltransferase 2. Cancer Res. 2001, 61, 8534-8539.
45. Roedel, E.Q.; Cafasso, D.E.; Lee, K.W.; Pierce, L.M. Pulmonary toxicity after exposure to military-relevant heavy metal tungsten alloy particles. Toxicol. Appl. Pharmacol. 2011, 259, 74-86.
46. Verma, R.; Xu, X.; Jaiswal, M.K.; Olsen, C.; Mears, D.; Caretti, G.; Galdzicki, Z. In vitro profiling of epigenetic modifications underlying heavy metal toxicity of tungsten-alloy and its components. Toxicol. Appl. Pharmacol. 2011, 253, 178-187.